We applied T2/T1-weighted MRI together with behavior, Hematoxylin&Eosin(HE)and immunohistochemistry fluorescence staining (IHC) to evaluate the role of microglial SMAD7, a novel therapeutic approach, in a TBI mouse model. The consistency between MRI results and behavior and myelin and neurnal marker outcomes suggest that the protective role of over-expression of microglial SMAD7 in TBI.
This abstract and the presentation materials are available to members only; a login is required.